Byetta is an injectable drug used to treat individuals with type II diabetes and was the first glucagon-like peptide-1 (GLP-1) receptor agonist to be approved by the FDA for diabetic treatment. Unfortunately, mounting evidence has linked Byetta and similar drugs to increasing cases of pancreatic cancer, which has resulted in litigation being pursued by our firm. Byetta simulates the pancreatic cells to produce insulin when blood sugar is high and was approved in the U.S. in April 2005. In 2007, that the FDA discovered pancreatitis cases in Byetta patients and proceeded with further warnings in 2008 when the drug cased a total of 6 deaths in patients who had developed pancreatitis. As a result of chronic pancreatitis risks associated with Byetta, which often go undiagnosed while the diabetes drug continues to be used, individuals may face an increased risk of developing cancer of the pancreas.
Helping Clients Across the Nation
At Rheingold Giuffra Ruffo & Plotkin LLP, our New York product liability attorneys have extensive experience handling cases involving dangerous drugs involving personal injury and wrongful death. We are focused on helping individuals achieve financial and emotional relief from the physical and financial hardships they are enduring. All suits for clients are filed individually and litigated in courts which are strategically advantageous for a client's individual claims.
Byetta & Pancreatic Cancer
Studies have shown that certain types of incretin mimetic diabetes drugs, including Byetta can increase the risk of pancreatitis and pancreatic cancer. These drugs increase insulin secretion and decreasing blood sugar levels and may cause severe and deadly side effects, including acute pancreatitis. Pancreatic cancer begins in the tissues of the pancreas and is often accompanied by a poor diagnosis because of its difficulty to identify. Cancerous cells spread quickly and are hardly ever detected in their early stage which is why it is a major contributor to cancer. We believe the evidence will show that premarket animal studies, which were not made public, showed this potential problem.
Symptoms of Byetta-related pancreatitis can include:
- Upper Abdominal Pain
- Tenderness or swelling of the abdomen
- Increased heart rate
- Jaundice (yellowing of the skin and teeth)
- Trouble breathing
Our attorneys are highly experienced and will work with you personally to determine the extent of the monetary damage this drug has caused you, and what legal remedies are at your disposal. Our ultimate goal is to help you obtain monetary compensation for the financial hardships you face. Our firm will litigate your case from start to finish, and we do not involve other firms.
Plaintiffs accuse the manufacturers of designing defective drugs, failure to warn, and breach of warranty, negligent misrepresentation, and fraudulent concealment. Lawsuits for defective drug injuries can be very complex as defective products cause life-changing, even fatal injuries to innocent individuals every year. In fact, studies show a significant increase in cancer cases due to the use of these drugs. If you or someone you love has suffered due to this type of negligence, it is important to speak to an experienced lawyer who can help you file a claim to:
- Seek compensation for injuries, medical expenses, pain, and suffering and other economic damages, as well as punitive damages you need to make it through this difficult time.
- Make sure others are protected from these destructive practices
Contact Us for a Case Evaluation
If you or a loved one developed pancreatic cancer after taking Byetta please contact us today, online or by telephone at (888) 260-0473 to speak with an experienced New York drug product liability law firm.